 |
The Journal of Neuroscience, February 1, 2006, 26(5):1596-1603; doi:10.1523/JNEUROSCI.4946-05.2006
 Previous Article | Next Article 
Neurobiology of Disease
The Lipoprotein Receptor LR11 Regulates Amyloid  Production and Amyloid Precursor Protein Traffic in Endosomal Compartments
Katrin Offe,1,2
Sara E. Dodson,1,2
James T. Shoemaker,1,4
Jason J. Fritz,1,4
Marla Gearing,1,3
Allan I. Levey,1,4 and
James J. Lah1,4
1Center for Neurodegenerative Disease, 2Graduate Program in Neuroscience, and 3Departments of Pathology and 4Neurology, Emory University, Atlanta, Georgia 30322
Correspondence should be addressed to Dr. James J. Lah, Center for Neurodegenerative Disease, 615 Michael Street, Suite 505 South, Atlanta, GA 30322. Email: jlah{at}emory.edu
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline and neuropathological changes, including the deposition of amyloid  (A) in senile plaques. The mechanisms causing the disease and A accumulation are not well understood, but important genetic associations with apolipoprotein E genotype and involvement of lipoprotein receptors have become apparent. LR11 (also known as SorLA), a member of the low-density lipoprotein receptor family, has been identified previously as an altered transcript in microarray analyses of samples from human AD cases. Here, we show neuronal expression of the lipoprotein receptor LR11 in control brain in regions vulnerable to AD neuropathology and marked reduction of LR11 expression in these regions in AD brains before cell death. Overexpression of LR11 drastically reduces levels of extracellular A and also lowers levels of total cellular amyloid precursor protein (APP). LR11 colocalizes with APP and regulates its trafficking in endocytic compartments, which are important intracellular sites for APP processing and A generation. Endogenous LR11 localizes to neuronal multivesicular bodies in both rat and human brain. The robust correlation between reduced LR11 expression and AD neuropathology and its potent effects on extracellular A levels suggest that this neuronal lipoprotein receptor could play an important role in AD pathogenesis.
Key words: LR11; sorLA; VPS10; lipoprotein receptors; amyloid ; amyloid precursor protein; Alzheimer’s disease; endocytic pathway
Received Sept. 18, 2005;
revised Dec. 16, 2005;
accepted Dec. 19, 2005.
Correspondence should be addressed to Dr. James J. Lah, Center for Neurodegenerative Disease, 615 Michael Street, Suite 505 South, Atlanta, GA 30322. Email: jlah{at}emory.edu
This article has been cited by other articles:
|
|
|
|
 
M. Rohe, M. Synowitz, R. Glass, S. M. Paul, A. Nykjaer, and T. E. Willnow
Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene Expression
J. Neurosci.,
December 9, 2009;
29(49):
15472 - 15478.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Cellini, A. Tedde, S. Bagnoli, S. Pradella, S. Piacentini, S. Sorbi, and B. Nacmias
Implication of Sex and SORL1 Variants in Italian Patients With Alzheimer Disease
Arch Neurol,
October 1, 2009;
66(10):
1260 - 1266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q.-L. Ma, D. R. Galasko, J. M. Ringman, H. V. Vinters, S. D. Edland, J. Pomakian, O. J. Ubeda, E. R. Rosario, B. Teter, S. A. Frautschy, et al.
Reduction of SorLA/LR11, a Sorting Protein Limiting {beta}-Amyloid Production, in Alzheimer Disease Cerebrospinal Fluid
Arch Neurol,
April 1, 2009;
66(4):
448 - 457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. T. Cuenco, K. L. Lunetta, C. T. Baldwin, A. C. McKee, J. Guo, L. A. Cupples, R. C. Green, P. H. St. George-Hyslop, H. Chui, C. DeCarli, et al.
Association of Distinct Variants in SORL1 With Cerebrovascular and Neurodegenerative Changes Related to Alzheimer Disease
Arch Neurol,
December 1, 2008;
65(12):
1640 - 1648.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Dodson, O. M. Andersen, V. Karmali, J. J. Fritz, D. Cheng, J. Peng, A. I. Levey, T. E. Willnow, and J. J. Lah
Loss of LR11/SORLA Enhances Early Pathology in a Mouse Model of Amyloidosis: Evidence for a Proximal Role in Alzheimer's Disease
J. Neurosci.,
November 26, 2008;
28(48):
12877 - 12886.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Cataldo, P. M. Mathews, A. B. Boiteau, L. C. Hassinger, C. M. Peterhoff, Y. Jiang, K. Mullaney, R. L. Neve, J. Gruenberg, and R. A. Nixon
Down Syndrome Fibroblast Model of Alzheimer-Related Endosome Pathology: Accelerated Endocytosis Promotes Late Endocytic Defects
Am. J. Pathol.,
August 1, 2008;
173(2):
370 - 384.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Rohe, A.-S. Carlo, H. Breyhan, A. Sporbert, D. Militz, V. Schmidt, C. Wozny, A. Harmeier, B. Erdmann, K. R. Bales, et al.
Sortilin-related Receptor with A-type Repeats (SORLA) Affects the Amyloid Precursor Protein-dependent Stimulation of ERK Signaling and Adult Neurogenesis
J. Biol. Chem.,
May 23, 2008;
283(21):
14826 - 14834.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Muhammad, I. Flores, H. Zhang, R. Yu, A. Staniszewski, E. Planel, M. Herman, L. Ho, R. Kreber, L. S. Honig, et al.
Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and A{beta} accumulation
PNAS,
May 20, 2008;
105(20):
7327 - 7332.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Lee, R. Cheng, L. S. Honig, J-P G. Vonsattel, L. Clark, and R. Mayeux
ASSOCIATION BETWEEN GENETIC VARIANTS IN SORL1 AND AUTOPSY-CONFIRMED ALZHEIMER DISEASE
Neurology,
March 11, 2008;
70(11):
887 - 889.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Shrivastava-Ranjan, V. Faundez, G. Fang, H. Rees, J. J. Lah, A. I. Levey, and R. A. Kahn
Mint3/X11{gamma} Is an ADP-Ribosylation Factor-dependent Adaptor that Regulates the Traffic of the Alzheimer's Precursor Protein from the Trans-Golgi Network
Mol. Biol. Cell,
January 1, 2008;
19(1):
51 - 64.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q.-L. Ma, B. Teter, O. J. Ubeda, T. Morihara, D. Dhoot, M. D. Nyby, M. L. Tuck, S. A. Frautschy, and G. M. Cole
Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer's Disease (AD): Relevance to AD Prevention
J. Neurosci.,
December 26, 2007;
27(52):
14299 - 14307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Schmidt, A. Sporbert, M. Rohe, T. Reimer, A. Rehm, O. M. Andersen, and T. E. Willnow
SorLA/LR11 Regulates Processing of Amyloid Precursor Protein via Interaction with Adaptors GGA and PACS-1
J. Biol. Chem.,
November 9, 2007;
282(45):
32956 - 32964.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Nielsen, C. Gustafsen, P. Madsen, J. R. Nyengaard, G. Hermey, O. Bakke, M. Mari, P. Schu, R. Pohlmann, A. Dennes, et al.
Sorting by the Cytoplasmic Domain of the Amyloid Precursor Protein Binding Receptor SorLA
Mol. Cell. Biol.,
October 1, 2007;
27(19):
6842 - 6851.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Gissen and E. R Maher
Cargos and genes: insights into vesicular transport from inherited human disease
J. Med. Genet.,
September 1, 2007;
44(9):
545 - 555.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. R. Scherzer, A. C. Eklund, L. J. Morse, Z. Liao, J. J. Locascio, D. Fefer, M. A. Schwarzschild, M. G. Schlossmacher, M. A. Hauser, J. M. Vance, et al.
Molecular markers of early Parkinson's disease based on gene expression in blood
PNAS,
January 16, 2007;
104(3):
955 - 960.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Wahle, D. R. Thal, M. Sastre, A. Rentmeister, N. Bogdanovic, M. Famulok, M. T. Heneka, and J. Walter
GGA1 Is Expressed in the Human Brain and Affects the Generation of Amyloid {beta}-Peptide
J. Neurosci.,
December 6, 2006;
26(49):
12838 - 12846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Bohm, N. M. Seibel, B. Henkel, H. Steiner, C. Haass, and W. Hampe
SorLA Signaling by Regulated Intramembrane Proteolysis
J. Biol. Chem.,
May 26, 2006;
281(21):
14547 - 14553.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
